| FADD |
FADD, MORT1: Protein FADD |
SQSTM1 |
SQSTM1: Uncharacterized protein SQSTM1 |
11.260 |
Evidence |
|
| CD40LG |
CD40LG, CD40L, TNFSF5, TRAP: CD40 ligand |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
11.260 |
Evidence |
|
| MSN |
MSN: Moesin |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
11.260 |
Evidence |
|
| CD44 |
IPI00305064 |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
11.260 |
Evidence |
|
| PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
11.260 |
Evidence |
|
| CD4 |
CD4: T-cell surface glycoprotein CD4 precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
11.260 |
Evidence |
|
| EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
C1QTNF4 |
C1QTNF4, CTRP4: Complement C1q tumor necrosis factor-related protein 4 precursor |
11.260 |
Evidence |
|
| EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
C1QTNF4 |
C1QTNF4, CTRP4: Complement C1q tumor necrosis factor-related protein 4 precursor |
11.260 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
TNFSF13B |
TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto |
11.260 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
PLAUR |
PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor |
11.260 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
OPTC |
OPTC, OPT: Opticin precursor |
11.260 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
C1QTNF4 |
C1QTNF4, CTRP4: Complement C1q tumor necrosis factor-related protein 4 precursor |
11.260 |
Evidence |
|
| FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
STAT3 |
|
11.260 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
AKAP12 |
AKAP12, AKAP250: A-kinase anchor protein 12 |
11.260 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
AKAP12 |
AKAP12, AKAP250: A-kinase anchor protein 12 |
11.260 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
H1FX |
H1FX: Histone H1x |
11.260 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
11.260 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
CD40LG |
CD40LG, CD40L, TNFSF5, TRAP: CD40 ligand |
11.260 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
STAT3 |
|
11.260 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PLAUR |
PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor |
11.260 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
11.250 |
Evidence |
|
| JUNB |
JUNB: Transcription factor jun-B |
SOX11 |
SOX11: Transcription factor SOX-11 |
11.250 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
ST14 |
ST14, PRSS14, SNC19, TADG15: Suppressor of tumorigenicity protein 14 |
11.250 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
GABRB1 |
GABRB1: Gamma-aminobutyric acid receptor subunit beta-1 precursor |
11.250 |
Evidence |
|
| FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
11.250 |
Evidence |
|